The Global Neglected Tropical Diseases Diagnosis Market is projected to grow at a CAGR of 4.5% during the forecast period, from 2022 to 2029, to reach a market size of USD 8.97 billion by 2029, up from USD 6.32 billion in 2022.Neglected Tropical Diseases Diagnosis Market Overview
Neglected Tropical Diseases (NTDs) diagnosis involves clinical assessment, laboratory testing, and advanced techniques. Healthcare providers conduct physical examinations, take medical histories, and use interviews to gather information. Laboratory tests include microscopic examination, serological tests, molecular tests (like PCR), and culture. Rapid diagnostic tests (RDTs) provide quick results in resource-limited settings. Imaging techniques like X-rays, ultrasounds, or CT scans help visualize disease extent and treatment response. Accurate diagnosis is crucial for initiating appropriate treatment and public health interventions to control and prevent the spread of NTDs. The Neglected Tropical Diseases (NTDs) market has gained significant attention in recent years, driven by the global health agenda's focus on combating these neglected diseases. NTDs, including dengue fever, Chagas disease, leprosy, lymphatic filariasis, and schistosomiasis, have far-reaching social and economic impacts, posing obstacles to the development and well-being of affected communities. The market primarily revolves around the development, production, and distribution of drugs, vaccines, diagnostics, and healthcare solutions tailored specifically to address NTDs. Pharmaceutical companies collaborate with research institutions, often with support from funding initiatives and partnerships, to develop new therapies and treatments.The NTDs market operates within resource-limited settings, presenting challenges in terms of affordability, accessibility, and infrastructure. Innovative pricing models, partnerships, and collaborations play a crucial role in ensuring the availability and affordability of essential interventions.The market's scope encompasses various dimensions, including drug development, vaccine research, diagnostics, treatment access, public health programs, and research funding. The aim is to tackle the unique challenges posed by NTDs, promoting innovation, collaboration, and sustainable solutions to improve the health and well-being of affected populations.To know about the Research Methodology :- Request Free Sample Report
Neglected Tropical Diseases Diagnosis Market Dynamics
Commercial Neglected Tropical Diseases Diagnosis Major Drivers Raising Awareness and International Health Campaigns: The increasing understanding of disregarded afflictions affecting tropical regions and their impact on vulnerable communities has resulted in amplified attention from worldwide health organizations, governments, and non-profit institutions. Initiatives like the World Health Organization's Strategy on Neglected Tropical Diseases and the London Proclamation on Neglected Tropical Diseases have aided in mobilizing resources and funding for the purpose of diagnosing and controlling these diseases. This intensified emphasis has generated a greater demand for enhanced diagnostic methods, thereby stimulating market expansion. Technological Progress in Diagnostic Techniques: The evolution of diagnostic technologies has substantially enhanced the capacity to accurately and swiftly diagnose neglected tropical diseases. Emerging methods, such as molecular diagnostics, point-of-care examinations, and innovative imaging technologies, have elevated the sensitivity, specificity, and accessibility of diagnosing these diseases. These technological advancements have not only enabled early and accurate detection but also facilitated surveillance and monitoring of disease prevalence, driving market growth. Neglected Tropical Diseases Diagnosis Market Opportunities The growing emphasis on enhancing research and development: The escalating acknowledgment of disregarded tropical illnesses as worldwide health concerns have spurred financial investments in research and development endeavors centered on the diagnosis of NTDs. Authorities, pharmaceutical corporations, and charitable institutions are dedicating resources to endorse the exploration and creation of groundbreaking diagnostic equipment, comprising inventive systems, on-the-spot devices, and cost-effective diagnostic resolutions. This unveils prospects for market participants to introduce unique commodities and broaden their range of offerings. Expansion of Healthcare Infrastructure in Low-Income Countries: Efforts to strengthen healthcare infrastructure in low-income countries have the potential to create opportunities in the NTD diagnosis market. Investments in healthcare systems, including laboratory facilities, trained personnel, and supply chains, can improve the access and availability of diagnostic services. Additionally, initiatives to decentralize diagnostic services, such as mobile clinics and telemedicine, can enhance diagnostic coverage in remote areas. These developments provide an avenue for market growth and the delivery of timely and effective NTD diagnosis to underserved populations. Neglected Tropical Diseases Diagnosis Market Major Restraints Affordability and Cost-Effectiveness: Affordability and cost-effectiveness of diagnostic tools and tests remain significant restraints in the NTDs diagnosis market. Many NTDs disproportionately affect populations in low-income countries, where affordability is a crucial factor. The development and production of cost-effective diagnostics suitable for resource-limited settings is essential to ensure wide-scale adoption and accessibility. Balancing the need for affordable diagnostics with the costs associated with research, development, and production presents a challenge for market players. Limited Market Incentives for Commercialization: The commercial viability of neglected tropical disease diagnostics is often limited due to the target population's low purchasing power. The market potential and return on investment for diagnostic companies may be perceived as insufficient, leading to limited interest from the private sector. This lack of market incentives can impede the development and availability of innovative diagnostic solutions. Overcoming these restraints requires collaborative efforts between public and private stakeholders, along with supportive policies and funding mechanisms to encourage investment in NTDs diagnosis. Neglected Tropical Diseases Diagnosis Market Challenges Limited Access to Healthcare in Resource-Limited Settings: Neglected tropical diseases primarily affect populations in low-income countries with limited access to healthcare infrastructure. Inadequate laboratory facilities, trained personnel, and diagnostic resources pose challenges in conducting accurate and timely diagnosis. The lack of reliable transportation systems and the remoteness of some regions further hinder access to diagnostic services, impeding the effective diagnosis and management of NTDs. Complexity and Diversity of Neglected Tropical Diseases: Neglected tropical diseases encompass a wide range of infectious diseases caused by different pathogens, presenting a challenge for diagnosis. These diseases often have overlapping clinical symptoms, making accurate diagnosis difficult without proper laboratory testing. Additionally, co-infections or co-endemicity of multiple NTDs in the same geographical area further complicate the diagnostic process. Developing diagnostic tools that can effectively differentiate between various NTDs and detect co-infections is a significant challenge for the market.Neglected Tropical Diseases Diagnosis Market Trends
In the Neglected Tropical Diseases (NTDs) Diagnosis Market, several significant trends are shaping the landscape. Firstly, there is a growing emphasis on the development and utilization of point-of-care (POC) diagnostic tests. These portable and rapid tests enable timely diagnosis and treatment in resource-limited settings, eliminating the need for complex laboratory infrastructure. Digital health technologies are revolutionizing NTDs diagnosis by integrating mobile health applications, telemedicine platforms, and remote monitoring tools. These technologies enable remote consultation, real-time data collection, and enhance disease surveillance, monitoring, and reporting capabilities. The market is also witnessing the rise of multiplex and combination diagnostics, allowing simultaneous detection of multiple NTDs or differentiation between various pathogens. This trend offers efficiency, cost-effectiveness, and faster results by integrating multiple tests into a single diagnostic assay. Lastly, the integration of artificial intelligence (AI) and machine learning technologies is enhancing diagnostic accuracy, efficiency, and automation. AI algorithms analyze large datasets, aid in image-based diagnostics, support disease surveillance, and enable predictive modeling for proactive interventions and targeted control strategies. These trends collectively reflect a dynamic and evolving NTDs diagnosis market, focusing on accessibility, technological advancements, collaborations, and the utilization of data-driven approaches to improve diagnostic capabilities and control the spread of neglected tropical diseases.Neglected Tropical Diseases Diagnosis Market Segment Analysis
Conventional diagnostic methods: This segment is expected to dominate the market in the coming years, owing to its low cost and ease of use. However, the molecular diagnostic methods segment is expected to grow at a faster rate, due to its high accuracy and sensitivity. Molecular diagnostic methods: This segment is expected to grow at a CAGR of 5.0% from 2023 to 2030, driven by the increasing demand for accurate and sensitive diagnostic tests. The development of new molecular diagnostic technologies, such as next-generation sequencing (NGS), is also expected to boost the growth of this segment. By Service Type: Centralized service: This segment is expected to dominate the market in the coming years, owing to the high volume of testing required for large-scale programs, such as mass screening programs. However, the point-of-care testing (POCT) segment is expected to grow at a faster rate, due to the increasing demand for rapid and convenient diagnostic testing. Point-of-care testing (POCT): This segment is expected to grow at a CAGR of 6.0% from 2023 to 2030, driven by the increasing demand for rapid and convenient diagnostic testing. POCT devices are portable and easy to use, making them ideal for use in remote areas or in settings where access to centralized testing facilities is limited. By End-User: Hospitals: Hospitals are the largest end-users of NTD diagnostic services. They provide diagnostic services to patients who are admitted to the hospital, as well as to patients who are seen in the outpatient clinic. Clinical laboratories: Clinical laboratories provide diagnostic services to a variety of healthcare providers, including hospitals, clinics, and doctor's offices. Others: This category includes other end-users of NTD diagnostic services, such as public health agencies, research institutions, and pharmaceutical companies. By Disease: Dengue: Dengue is a mosquito-borne disease that is endemic in tropical and subtropical regions. The disease is characterized by fever, headache, muscle pain, and rash. Dengue is a major public health problem, with an estimated 400 million cases reported worldwide each year. Chikungunya: Chikungunya is a mosquito-borne disease that is similar to dengue. The disease is characterized by fever, joint pain, and rash. Chikungunya is also a major public health problem, with an estimated 100 million cases reported worldwide each year. Rabies: Rabies is a viral disease that is transmitted through the bite of an infected animal. The disease is fatal if not treated. Rabies is a major public health problem in developing countries, with an estimated 59,000 deaths reported worldwide each year.Neglected Tropical Diseases Diagnosis Market Regional Insights
Asia Pacific: Asia Pacific has a significant burden of neglected tropical diseases due to its large population and tropical climate. Countries such as India, Indonesia, and Bangladesh face challenges in diagnosing and managing NTDs. The market in this region is driven by increasing investments in healthcare infrastructure, rising awareness, and government initiatives to control NTDs. Point-of-care diagnostics and telemedicine solutions are gaining traction to overcome accessibility barriers in remote areas. Additionally, collaborations between governments, research institutions, and diagnostic companies are fostering innovation and market growth. Europe: While Europe is not heavily burdened by neglected tropical diseases, it plays a vital role in NTD diagnosis through research, development, and collaborations. European countries contribute to the development of innovative diagnostic technologies, particularly in the field of molecular diagnostics and imaging. European organizations often provide funding and technical support to NTD control programs in low-income countries. Additionally, Europe hosts international conferences and symposiums focused on NTDs, facilitating knowledge sharing and fostering partnerships. North America: North America primarily contributes to the Neglected Tropical Diseases Diagnosis Market through research and development efforts, as well as funding support. Academic and research institutions collaborate with global health organizations to develop improved diagnostics for NTDs. Pharmaceutical companies based in North America engage in partnerships and initiatives to address the diagnostic needs of NTD-affected regions. The market is also influenced by advocacy groups and non-profit organizations raising awareness and mobilizing resources for NTD diagnosis and control. Latin America and LAMEA (Latin America, Middle East, and Africa): The LAMEA region faces a substantial burden of neglected tropical diseases, with diverse disease profiles across countries. Lack of access to healthcare infrastructure and limited resources present challenges for NTD diagnosis. The market in LAMEA is driven by efforts to improve diagnostic capacity, collaborations with international organizations, and initiatives by governments and NGOs. Point-of-care diagnostics, telemedicine solutions, and mobile health applications are being utilized to overcome geographical and logistical barriers. Increasing investments in healthcare infrastructure and partnerships with diagnostic companies are expected to fuel market growth in the region.Neglected Tropical Diseases Diagnosis Market Competitive Landscape
The Neglected Tropical Diseases (NTDs) Diagnosis Market has a competitive landscape comprising pharmaceutical companies, diagnostic companies, research institutions, non-profit organizations, government agencies, and global health organizations. Large pharmaceutical companies contribute their resources and global reach to develop diagnostic tools and therapies for NTDs. Specialized diagnostic companies focus on developing and manufacturing tailored diagnostic tests. Research institutions and non-profit organizations conduct research, collaborate with industry partners, and work on capacity building and implementation programs. Government agencies provide funding and set priorities, while global health organizations offer technical expertise and coordination. Partnerships and collaborations between stakeholders drive innovation and resource mobilization. The competitive landscape is characterized by ongoing research and development, innovation in diagnostic technologies, and efforts to overcome barriers in NTDs diagnosis. The focus is on developing accurate, affordable, and accessible diagnostic solutions to address the unique challenges of neglected tropical diseases and improve health outcomes for affected populations.Neglected Tropical Diseases Diagnosis Market Scope: Inquire before buying
Neglected Tropical Diseases Diagnosis Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 6.32 Bn. Forecast Period 2023 to 2029 CAGR: 4.5% Market Size in 2029: US $ 8.97 Bn. Segments Covered: by Diagnostic Method Conventional diagnostic methods Molecular diagnostic methods by Service Type Centralized service Point of care testing(POCT) by End-User Hospitals Clinical Laboratories Others by Disease Dengue Chikungunya Rabies Neglected Tropical Diseases Diagnosis Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest) South America (Brazil, Argetina and Rest of South America)Neglected Tropical Diseases Diagnosis Market Major Competitors
1. Abbott Laboratories 2. Bio-Rad Laboratories 3. Beckman Coulter 4. Cepheid 5. Chembio Diagnostic Systems 6. Danaher Corporation 7. DiaSorin 8. Foundation for Innovative New Diagnostics (FIND) 9. Fujirebio 10. Hologic, Inc. 11. Meridian Bioscience, Inc. 12. PerkinElmer, Inc. 13. QIAGEN 14. Roche Diagnostics 15. Siemens Healthineers 16. Thermo Fisher Scientific 17. bioMérieux SA 18. GenMark Diagnostics, Inc. 19. HiberGene Diagnostics 20. InBios International, Inc. 21. Luminex Corporation 22. MyBiosource 23. OraSure Technologies, Inc. 24. Quidel Corporation 25. Trinity BiotechFAQS:
1. What are the growth drivers for the Neglected Tropical Diseases Diagnosis Market? Ans. The growth drivers for the Neglected Tropical Diseases Diagnosis Market are the increasing popularity of cloud gaming, the growing demand for high-quality gaming experiences, and the rising penetration of gaming consoles in emerging markets. 2. What is the major restraint for the Neglected Tropical Diseases Diagnosis Market growth? Ans. The major restraint for the Neglected Tropical Diseases Diagnosis Market growth is the high cost of gaming consoles and games. 3. Which region is expected to lead the global Neglected Tropical Diseases Diagnosis Market during the forecast period? Ans. Based on current trends and market analysis, Asia Pacific is expected to lead the global Neglected Tropical Diseases Diagnosis Market during the forecast period. 4. What is the projected market size & growth rate of the Neglected Tropical Diseases Diagnosis Market? Ans. The global Commercial Neglected Tropical Diseases Diagnosis size is expected to reach USD 52.2 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2029. 5. What segments are covered in the Neglected Tropical Diseases Diagnosis Market report? Ans. The segments covered in the Neglected Tropical Diseases Diagnosis Market report are Diagnostic method, service type, end user, and disease.
1. Neglected Tropical Diseases Diagnosis Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Neglected Tropical Diseases Diagnosis Market: Dynamics 2.1. Neglected Tropical Diseases Diagnosis Market Trends by Region 2.1.1. North America Neglected Tropical Diseases Diagnosis Market Trends 2.1.2. Europe Neglected Tropical Diseases Diagnosis Market Trends 2.1.3. Asia Pacific Neglected Tropical Diseases Diagnosis Market Trends 2.1.4. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Trends 2.1.5. South America Neglected Tropical Diseases Diagnosis Market Trends 2.2. Neglected Tropical Diseases Diagnosis Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Neglected Tropical Diseases Diagnosis Market Drivers 2.2.1.2. North America Neglected Tropical Diseases Diagnosis Market Restraints 2.2.1.3. North America Neglected Tropical Diseases Diagnosis Market Opportunities 2.2.1.4. North America Neglected Tropical Diseases Diagnosis Market Challenges 2.2.2. Europe 2.2.2.1. Europe Neglected Tropical Diseases Diagnosis Market Drivers 2.2.2.2. Europe Neglected Tropical Diseases Diagnosis Market Restraints 2.2.2.3. Europe Neglected Tropical Diseases Diagnosis Market Opportunities 2.2.2.4. Europe Neglected Tropical Diseases Diagnosis Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Neglected Tropical Diseases Diagnosis Market Drivers 2.2.3.2. Asia Pacific Neglected Tropical Diseases Diagnosis Market Restraints 2.2.3.3. Asia Pacific Neglected Tropical Diseases Diagnosis Market Opportunities 2.2.3.4. Asia Pacific Neglected Tropical Diseases Diagnosis Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Drivers 2.2.4.2. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Restraints 2.2.4.3. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Opportunities 2.2.4.4. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Challenges 2.2.5. South America 2.2.5.1. South America Neglected Tropical Diseases Diagnosis Market Drivers 2.2.5.2. South America Neglected Tropical Diseases Diagnosis Market Restraints 2.2.5.3. South America Neglected Tropical Diseases Diagnosis Market Opportunities 2.2.5.4. South America Neglected Tropical Diseases Diagnosis Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Neglected Tropical Diseases Diagnosis Industry 2.8. Analysis of Government Schemes and Initiatives For Neglected Tropical Diseases Diagnosis Industry 2.9. Neglected Tropical Diseases Diagnosis Market Trade Analysis 2.10. The Global Pandemic Impact on Neglected Tropical Diseases Diagnosis Market 3. Neglected Tropical Diseases Diagnosis Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 3.1.1. Conventional diagnostic methods 3.1.2. Molecular diagnostic methods 3.2. Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 3.2.1. Centralized service 3.2.2. Point of care testing(POCT) 3.3. Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 3.3.1. Hospitals 3.3.2. Clinical Laboratories 3.3.3. Others 3.4. Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 3.4.1. Dengue 3.4.2. Chikungunya 3.4.3. Rabies 3.5. Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Region (2022-2029) 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. Middle East and Africa 3.5.5. South America 4. North America Neglected Tropical Diseases Diagnosis Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 4.1.1. Conventional diagnostic methods 4.1.2. Molecular diagnostic methods 4.2. North America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 4.2.1. Centralized service 4.2.2. Point of care testing(POCT) 4.3. North America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 4.3.1. Hospitals 4.3.2. Clinical Laboratories 4.3.3. Others 4.4. North America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 4.4.1. Dengue 4.4.2. Chikungunya 4.4.3. Rabies 4.5. North America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Country (2022-2029) 4.5.1. United States 4.5.1.1. United States Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 4.5.1.1.1. Conventional diagnostic methods 4.5.1.1.2. Molecular diagnostic methods 4.5.1.2. United States Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 4.5.1.2.1. Centralized service 4.5.1.2.2. Point of care testing(POCT) 4.5.1.3. United States Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 4.5.1.3.1. Hospitals 4.5.1.3.2. Clinical Laboratories 4.5.1.3.3. Others 4.5.1.4. United States Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 4.5.1.4.1. Dengue 4.5.1.4.2. Chikungunya 4.5.1.4.3. Rabies 4.5.2. Canada 4.5.2.1. Canada Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 4.5.2.1.1. Conventional diagnostic methods 4.5.2.1.2. Molecular diagnostic methods 4.5.2.2. Canada Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 4.5.2.2.1. Centralized service 4.5.2.2.2. Point of care testing(POCT) 4.5.2.3. Canada Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 4.5.2.3.1. Hospitals 4.5.2.3.2. Clinical Laboratories 4.5.2.3.3. Others 4.5.2.4. Canada Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 4.5.2.4.1. Dengue 4.5.2.4.2. Chikungunya 4.5.2.4.3. Rabies 4.5.3. Mexico 4.5.3.1. Mexico Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 4.5.3.1.1. Conventional diagnostic methods 4.5.3.1.2. Molecular diagnostic methods 4.5.3.2. Mexico Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 4.5.3.2.1. Centralized service 4.5.3.2.2. Point of care testing(POCT) 4.5.3.3. Mexico Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 4.5.3.3.1. Hospitals 4.5.3.3.2. Clinical Laboratories 4.5.3.3.3. Others 4.5.3.4. Mexico Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 4.5.3.4.1. Dengue 4.5.3.4.2. Chikungunya 4.5.3.4.3. Rabies 5. Europe Neglected Tropical Diseases Diagnosis Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 5.1. Europe Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 5.1. Europe Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 5.1. Europe Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 5.5. Europe Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Country (2022-2029) 5.5.1. United Kingdom 5.5.1.1. United Kingdom Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 5.5.1.2. United Kingdom Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 5.5.1.3. United Kingdom Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 5.5.1.4. United Kingdom Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 5.5.2. France 5.5.2.1. France Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 5.5.2.2. France Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 5.5.2.3. France Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 5.5.2.4. France Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 5.5.3. Germany 5.5.3.1. Germany Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 5.5.3.2. Germany Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 5.5.3.3. Germany Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 5.5.3.4. Germany Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 5.5.4. Italy 5.5.4.1. Italy Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 5.5.4.2. Italy Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 5.5.4.3. Italy Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 5.5.4.4. Italy Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 5.5.5. Spain 5.5.5.1. Spain Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 5.5.5.2. Spain Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 5.5.5.3. Spain Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 5.5.5.4. Spain Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 5.5.6. Sweden 5.5.6.1. Sweden Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 5.5.6.2. Sweden Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 5.5.6.3. Sweden Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 5.5.6.4. Sweden Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 5.5.7. Austria 5.5.7.1. Austria Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 5.5.7.2. Austria Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 5.5.7.3. Austria Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 5.5.7.4. Austria Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 5.5.8. Rest of Europe 5.5.8.1. Rest of Europe Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 5.5.8.2. Rest of Europe Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 5.5.8.3. Rest of Europe Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 5.5.8.4. Rest of Europe Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6. Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.2. Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.3. Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.4. Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6.5. Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Country (2022-2029) 6.5.1. China 6.5.1.1. China Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.5.1.2. China Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.5.1.3. China Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.5.1.4. China Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6.5.2. S Korea 6.5.2.1. S Korea Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.5.2.2. S Korea Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.5.2.3. S Korea Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.5.2.4. S Korea Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6.5.3. Japan 6.5.3.1. Japan Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.5.3.2. Japan Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.5.3.3. Japan Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.5.3.4. Japan Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6.5.4. India 6.5.4.1. India Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.5.4.2. India Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.5.4.3. India Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.5.4.4. India Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6.5.5. Australia 6.5.5.1. Australia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.5.5.2. Australia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.5.5.3. Australia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.5.5.4. Australia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6.5.6. Indonesia 6.5.6.1. Indonesia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.5.6.2. Indonesia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.5.6.3. Indonesia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.5.6.4. Indonesia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6.5.7. Malaysia 6.5.7.1. Malaysia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.5.7.2. Malaysia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.5.7.3. Malaysia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.5.7.4. Malaysia Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6.5.8. Vietnam 6.5.8.1. Vietnam Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.5.8.2. Vietnam Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.5.8.3. Vietnam Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.5.8.4. Vietnam Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6.5.9. Taiwan 6.5.9.1. Taiwan Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.5.9.2. Taiwan Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.5.9.3. Taiwan Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.5.9.4. Taiwan Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 6.5.10. Rest of Asia Pacific 6.5.10.1. Rest of Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 6.5.10.2. Rest of Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 6.5.10.3. Rest of Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 6.5.10.4. Rest of Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 7. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 7.2. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 7.3. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 7.4. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 7.5. Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Country (2022-2029) 7.5.1. South Africa 7.5.1.1. South Africa Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 7.5.1.2. South Africa Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 7.5.1.3. South Africa Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 7.5.1.4. South Africa Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 7.5.2. GCC 7.5.2.1. GCC Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 7.5.2.2. GCC Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 7.5.2.3. GCC Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 7.5.2.4. GCC Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 7.5.3. Nigeria 7.5.3.1. Nigeria Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 7.5.3.2. Nigeria Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 7.5.3.3. Nigeria Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 7.5.3.4. Nigeria Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 7.5.4. Rest of ME&A 7.5.4.1. Rest of ME&A Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 7.5.4.2. Rest of ME&A Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 7.5.4.3. Rest of ME&A Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 7.5.4.4. Rest of ME&A Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 8. South America Neglected Tropical Diseases Diagnosis Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 8.2. South America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 8.3. South America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User(2022-2029) 8.4. South America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 8.5. South America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Country (2022-2029) 8.5.1. Brazil 8.5.1.1. Brazil Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 8.5.1.2. Brazil Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 8.5.1.3. Brazil Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 8.5.1.4. Brazil Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 8.5.2. Argentina 8.5.2.1. Argentina Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 8.5.2.2. Argentina Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 8.5.2.3. Argentina Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 8.5.2.4. Argentina Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 8.5.3. Rest Of South America 8.5.3.1. Rest Of South America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Diagnostic Method (2022-2029) 8.5.3.2. Rest Of South America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Service Type (2022-2029) 8.5.3.3. Rest Of South America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by End-User (2022-2029) 8.5.3.4. Rest Of South America Neglected Tropical Diseases Diagnosis Market Size and Forecast, by Disease (2022-2029) 9. Global Neglected Tropical Diseases Diagnosis Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Neglected Tropical Diseases Diagnosis Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Abbott Laboratories 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Bio-Rad Laboratories 10.3. Beckman Coulter 10.4. Cepheid 10.5. Chembio Diagnostic Systems 10.6. Danaher Corporation 10.7. DiaSorin 10.8. Foundation for Innovative New Diagnostics (FIND) 10.9. Fujirebio 10.10. Hologic, Inc. 10.11. Meridian Bioscience, Inc. 10.12. PerkinElmer, Inc. 10.13. QIAGEN 10.14. Roche Diagnostics 10.15. Siemens Healthineers 10.16. Thermo Fisher Scientific 10.17. bioMérieux SA 10.18. GenMark Diagnostics, Inc. 10.19. HiberGene Diagnostics 10.20. InBios International, Inc. 10.21. Luminex Corporation 10.22. MyBiosource 10.23. OraSure Technologies, Inc. 10.24. Quidel Corporation 10.25. Trinity Biotech 11. Key Findings 12. Industry Recommendations 13. Neglected Tropical Diseases Diagnosis Market: Research Methodology 14. Terms and Glossary